Virtual Agents with Augmented Reality in Digital Healthcare

Jeong, Harim; Yoo, Joo Hun; Song, Hayeon

doi:10.1109/ictc55196.2022.9952909

Cited by 6 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, one study compared humanoid and zoomorphic (animal-like) agents' effect in a mental health context. The findings revealed that users had a more enjoyable experience with the zoomorphic agents, leading to a higher intention for continued use [36]. From these results, it becomes evident that the significance of anthropomorphism does not necessarily imply that the agent must take on a human form.…”

Section: Agent Designmentioning

confidence: 91%

Virtual Agents in DTx: Focusing on Usability and Therapeutic Effectiveness

Jeong,

Yoo,

Goh

et al. 2023

Electronics

Self Cite

View full text Add to dashboard Cite

In the emergent field of digital therapeutics (DTx), this study examines the impact of virtual agent design on usability and therapeutic outcomes. Emphasizing the virtual agent’s role, our research highlights a marked therapeutic effect tied to the DTx’s developed parameters. Continuous usage, influenced by perceived usefulness, user attitudes, and intrinsic enjoyment, emerges as a crucial determinant for desired outcomes. The study finds anthropomorphism and agent likeability as pivotal factors in enhancing user experience and promoting sustained DTx use. Although focusing on mental health, particularly depression, the implications suggest varied results across DTx types. Given these insights, our findings advocate for a deeper exploration into agent-centric DTx designs, particularly in mental health applications. The nuances of user engagement with these therapeutic tools, especially in treating conditions like depression, demonstrate a diverse range of effects and underscore the importance of personalized approaches in digital therapeutics. This study’s outcomes not only shed light on the significant role of virtual agents but also call for continuous innovation and research in this evolving domain.

show abstract

Section: Agent Designmentioning

confidence: 91%

Virtual Agents in DTx: Focusing on Usability and Therapeutic Effectiveness

Jeong,

Yoo,

Goh

et al. 2023

Electronics

Self Cite

View full text Add to dashboard Cite

show abstract

“…Furthermore, the therapeutic alliance is also considered necessary, especially in mental-healthcare-related areas where DTx has been most widely applied in recent years. The therapeutic alliance (TA), which refers to the rapport and the relationship between physicians and patients in existing mental health treatment programs, remains a crucial factor in digital formation [44]. Therefore, to secure such a therapeutic alliance, the HCI factors must be considered [45].…”

Section: Hci Factorsmentioning

confidence: 99%

Cutting-Edge Technologies for Digital Therapeutics: A Review and Architecture Proposals for Future Directions

2023

Self Cite

View full text Add to dashboard Cite

Digital therapeutics, evidence-based treatments delivered through software programs, are revolutionizing healthcare by utilizing cutting-edge computing technologies. Unlike conventional medical treatment methods, digital therapeutics are based on multiple information technologies, from data collection to analysis algorithms, and treatment support approaches. In this research, we provide a comprehensive overview of the latest technologies involved in the development of digital therapeutics and highlight specific technologies necessary for the future growth of the rapidly evolving digital therapeutics market. Furthermore, we present a system design of digital therapeutics for depression, currently being developed by our research team, to provide a detailed explanation of the technical process. Digital therapeutics require various technical supports, such as collecting user data in a security-enhanced medical environment, processing and analyzing the collected data, and providing personalized treatment methods to the user. The findings from this research will enable digital therapeutic companies to enhance their product performance, consequently bolstering their market competitiveness. Additionally, the research can be further extended to explore applicable methodologies at different stages of digital therapeutic environments.

show abstract